Article,

Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?

, , , and .
Clinical Drug Investigation, 37 (5): 415--422 (February 2017)
DOI: 10.1007/s40261-017-0503-6

Meta data

Tags

Users

  • @jepcastel

Comments and Reviews